Table 1.
Perioperative characteristics of 400 living‐donor liver transplantation (LDLT) cases
| Patients (n = 400) | |
|---|---|
| Recipient age, years | 55 (46–60) |
| Sex, male/female | 198 (49)/202 (51) |
| Indication for LDLT | |
| Hepatocellular carcinoma | 138 (35) |
| HBV/HCV‐associated liver cirrhosis | 81 (20) |
| PBC/PSC | 67 (17) |
| Others | 114 (28) |
| HCV/not | 136 (34) /264 (66) |
| ALF/not | 27 (7)/373 (93) |
| Malignant/benign | 131 (33)/269 (67) |
| ABO compatibility, incompatible/not | 99 (25)/301 (75) |
| Preoperative medical condition, at home/hospitalized/ICU | 300(75)/71(18)/29(7) |
| CPT score, A/B/C | 24 (6)/100 (25)/276 (69) |
| MELD score | 18 (14–24) |
| Donor age, years | 45 (33–55) |
| Graft type, left−/right‐side | 153 (38)/246 (62) |
| GRWR, % | 0.90 (0.76–1.05) |
| Splenectomy/not | 222 (58)/162 (42) |
| Operation time, h | 13.6 (12.1–15.6) |
| Blood loss, g | 6140 (3580–10 768) |
| Cold ischemic time, min | 90 (59–146) |
| Warm ischemic time, min | 42 (36–52) |
| Final PVP, mmHg | 13 (11–15) |
Data are presented as median (interquartile range) for continuous variables and n (%) for categorical variables.
ALF, acute liver failure; CPT, Child–Pugh–Turcotte; GRWR, graft‐versus‐recipient weight ratio; HBV, hepatitis B virus; HCV, hepatitis C virus; ICU, intensive care unit; MELD, Model for End‐stage Liver Disease; PBC, primary biliary cholangitis/cirrhosis; PSC, primary sclerosing cholangitis; PVP, portal venous pressure.